Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of EVO756 for the Prevention of Migraine in Adults

NCT07616128 is registered in ClinicalTrials.gov with Evommune, Inc. as lead sponsor.

NCT NCT07616128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07616128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of EVO756 for the Prevention of Migraine in Adults
Lead sponsor
Evommune, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
July 29, 2026
Completion date
November 30, 2027
Enrollment
330 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

migraine